Monitor future commercial adoption metrics and sales figures to assess actual impact of these guidelines on LIBERTY system uptake; no immediate financial implications.
Price Chart
Executive Summary
Microbot Medical announced that updated occupational safety guidelines from SIR and CIRSE highlight radiation and ergonomic risks in interventional radiology, potentially strengthening the commercial position of its LIBERTY Endovascular Robotic System. The guidelines are endorsed by at least nine medical societies.
Key Facts
- Society of Interventional Radiology (SIR) and Cardiovascular and Interventional Radiological Society of Europe (CIRSE) released updated joint guidelines on occupational protection in interventional radiology.
- The guidelines address radiation exposure, musculoskeletal risks, and for the first time include radiation protection during pregnancy for female practitioners.
- At least nine medical societies endorse the guidelines, including AMA, ACC, SCAI, and SVS.
- The LIBERTY system is positioned as a solution to reduce radiation exposure and physical strain for physicians.
Financial Impact
No financial impact disclosed; this is a promotional update on external guidelines.
Risk Factors
- Commercial adoption of the LIBERTY system may not increase despite favorable guidelines.
- Regulatory or reimbursement challenges could limit market penetration.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-018453 |
| Exhibit: ex99-1.htm | 0001493152-26-018453 |
| Document: 0001493152-26-018453-index-headers.html | 0001493152-26-018453 |
| Document: 0001493152-26-018453-index.html | 0001493152-26-018453 |
| Document: 0001493152-26-018453.txt | 0001493152-26-018453 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 8-K | $0.9739 $0.9417 | ▼ −3.31% | ▼ −4.02% | $0.9417 (−3.31%) |
Oct 20, 2026 6d ago | 8-K | $0.9475 $0.9401 | ▼ −0.78% | ▼ −1.31% | $0.9417 (−0.61%) |
Oct 6, 2026 20d ago | 8-K | $1.07 $1.12 | ▲ +4.67% | ▲ +4.91% | $0.9417 (−11.99%) |
Oct 6, 2026 20d ago | Press Release | $1.07 $1.12 | ▲ +4.67% | ▲ +4.91% | $0.9417 (−11.99%) |
Sep 28, 2026 28d ago | 8-K | $1.25 $1.25 | ▼ −0.40% | ▼ −0.22% | $0.9417 (−24.66%) |
Aug 11, 2026 10w ago | 8-K | $1.68 $1.74 | ▲ +3.27% | ▲ +3.02% | $0.9417 (−43.95%) |
Jul 21, 2026 13w ago | 8-K | $1.80 $1.77 | ▼ −1.67% | ▼ −1.55% | $0.9417 (−47.68%) |
Jul 7, 2026 15w ago | 8-K | $1.90 $1.87 | ▼ −1.58% | ▼ −1.27% | $0.9417 (−50.44%) |
Jun 30, 2026 16w ago | 8-K | $1.95 $1.91 | ▼ −2.05% | ▼ −1.92% | $0.9417 (−51.71%) |
Jun 16, 2026 18w ago | 8-K | $1.82 $1.88 | ▲ +3.30% | ▲ +4.55% | $0.9417 (−48.26%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers